News

Thomas Fratacci

Thomas is Group CFO of SPRIM GLOBAL INVESTMENTS, overseeing Finance for the Sprim portfolio and TrialCap activities. He is responsible for all finance functions within the Group, focusing more specifically on financing rounds and exits for portfolio investments. He sits at the board of several portfolio companies. Thomas has 20 years of experience in corporate finance and business management in B2B environment. Prior to SPRIM, Thomas started his career in financial audit and advisory services, with Arthur Andersen, EY, and KPMG. He spent 10 years with the WPP Group as CFO and then CEO for Kantar AV France, overseeing consulting activities in France, Italy, and Russia. Thomas also participated in several successful startup projects in Europe and the US.

Contact Us

    RheumaGen was founded to relieve the burden that individuals suffering from autoimmune diseases have carried for so long. Mindful also of our own family members who are patients, we are not interested in incremental improvements. We seek cures; we seek remission.